Accolade Recognises Growth of ClinTec International’s Innovative Global Academy of Clinical Research Excellence (ACRE)
NEW YORK--(BUSINESS WIRE)-- ClinTec International is proud to be announced as winners of the prestigious ‘Business Innovation of the Year’ award sponsored by Microsoft presented during the Scottish Business Awards, held at the Edinburgh International Conference Centre on the 12th May 2014. Dr Rabinder Buttar, CEO and Chairman of ClinTec International, was presented the award in a ceremony with over 1,900 business people present. Attending the event was Global Entrepreneur Sir Richard Branson – who earlier met Dr Buttar and said “Well done to the ClinTec team for building an entrepreneurial, innovative global business”. Sir Richard Branson took part in a live Q&A session hosted by the broadcaster Alastair Stewart. Amongst the many key figures present at the Awards dinner and ceremony were First Minister of Scotland Rt. Honourable Alex Salmond MSP, Secretary of State for Scotland, the Rt. Honourable Alistair Carmichael MP and Chairman of the Awards, Sir Tom Hunter.
Dr Buttar said “ClinTec International is delighted to receive this prestigious award in recognition of all its hard work and dedication. As a global entrepreneurial company, with a presence in over fifty countries, innovation is at the heart of everything that we do”.
First Minister said ClinTec is well recognised as a successful global business operating from Scotland and Dr Buttar as one of our outstanding women in science. Dr Buttar and her International team attended the First Minister’s event at his official residence in Edinburgh, where Professor Andrea Nolan, Principal of Edinburgh Napier, received an honorary OBE by the First Minister on behalf of her Majesty Queen Elizabeth II.
The innovative business idea developed by ClinTec International was the growth of its Academy of Clinical Research Excellence (ACRE). In collaboration with the renowned Edinburgh Napier University, the ClinTec Academy, ACRE has delivered an innovative online Masters Degree programme in International Clinical Research and Technology and so far enrolled students from 15 different countries. In addition, ACRE now also offers a wide range of other University Certified training courses to address the learning needs globally of all clinical research professionals and through this it is shaping the future of training for clinical researchers on a global scale and driving standards even higher. For more information please contact email@example.com.
ClinTec International is a medium sized Contract Research Organisation with presence in over fifty countries globally, providing innovative clinical development services and functional service solutions exactly tailored to client needs. ClinTec addresses in a fast flexible and focussed way the needs of its diverse range of clients – including 7 of the top 10 pharmaceutical companies in the world to smaller virtual biotech companies. With the dedication of committed and knowledgeable Country Managers present in all regions of the world including the Middle East and North Africa, they are able to provide expertise on local regulations and use their long established local contacts to ensure that clinical trials are delivered smoothly on time and on budget. The size and carefully selected management structure at ClinTec International has a huge advantage over other CROs as senior management can intervene and give strategic advice when needed, at any time, throughout the project. As an entrepreneurial company, ClinTec International’s philosophy is to strategically align their services with clients’ needs, offering customised innovative truly flexible clinical research solutions. ClinTec is a certified women- owned business and embraces diversity.
ClinTec is attending the Diversity for Science Alliance conference on the 20th May in New Jersey where Pharmaceutical companies like Merck, Pfizer, Astra Zeneca and Abbvie are meeting with innovative women owned businesses such as ClinTec.
For media enquiries:
De Facto Communications
+44 (0) 207 203 6740